Skip to content

Abbott ABT Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$3.4M-20.9%
Haemonetics logo
HaemoneticsHAE
$1.15M+127%
Artivion logo
ArtivionAORT
$1.25M-70.1%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$2.78M-78.9%
DexCom logo
DexComDXCM
$12.7M-10.6%
AngioDynamics logo
AngioDynamicsANGO
$716K-20.0%

Other financials

Income statement

See full
Revenue$11.2B+7.8%
Gross profit$6.3B+6.5%
Operating income$1.3B-20.6%
Net income$1.1B-18.7%
EPS (diluted)$0.61-19.7%

Balance sheet

See full
Cash & equivalents$6.8B+4.1%
Total debt$34.0B+157%
Total equity$52.1B+6.7%
Total assets$110.43B+35.6%

Cash flow

See full
Operating cash flow$1.3B-7.2%
CapEx$399.0M-17.6%
Free cash flow$916.0M-1.8%

Valuation

See full
Market cap$158.05B-32.0%
Enterprise value$185.3B-22.5%
P/E25.2×+8.5×
P/S3.5×-1.9×

Profitability

See full
Gross margin56.3%+0.4pp
Operating margin17.1%+0.2pp
Net margin13.9%-18.0pp
FCF margin16.3%+0.6pp

Returns & leverage

See full
Return on equity12.4%-18.4pp
Debt / equity0.7×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Abbott's stock issuance proceeds?
Abbott (ABT) reported stock issuance proceeds of $116M in Q1 2026.
How has Abbott's stock issuance proceeds changed year-over-year?
Abbott's stock issuance proceeds decreased by 59.6% year-over-year, from $287M to $116M.
What is the long-term trend for Abbott's stock issuance proceeds?
Over 4 years (2021 to 2025), Abbott's stock issuance proceeds has grown at a 11.6% compound annual growth rate (CAGR), from $255M to $396M.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.